Blogs

The Toolbox - A dockerized pharmacometrics system

pmx-docker is a repository of docker containers designed to allow easy deployment of software tools for quantitative modeling and simulation activities. In the first release phase, four essential M&S related software are being deployed - R with Rstudio server NONMEM Perl Speaks NONMEM (PsN) Piranajs The project is currently in a testing phase and the product will be released to the community by March 1, 2017. This post will be updated closer to the release date.

Continue reading

Preprint your publications on BioRxiv

BioRxiv is the new home to pre-print publications for all disciplines involved in clinical drug development and therapeutics! Check out the new Drug Development and Clinical Therapeutics (#ddct) channel on the well-know BioRxiv pre-print site (channels are listed in a menu on the upper right side of the main page). Pre-prints provide rapid dissemination of knowledge with an opportunity to receive dynamic and continuous feedback from multiple reviewers that can improve the quality of your publication.

Continue reading

DDMore Model Repository

Access to curated and shared knowledge this post has been directly take from the ddmore model repository website An open, publicly available, free-to-use Model Repository that is indexed, fully searchable, and supported by peer review. The Model Repository enables display and search of key model features and elements via a structured and curated annotation system. The flexibility and power of the Model Repository is showcased by a range of “proof of concept” drug and disease models consisting of published pharmacokinetic (PK), pharmacodynamic (PD), PK-PD, physiologically-based PK (PBPK), statistical and systems biology models.

Continue reading

Open Source Tools in Pharmacometrics

The 7th American Confernce in Pharmacometrics was held in Seattle, Washington from October 23 - 27, 2016. On the last day of the conference, there was a session named - “An Overview of Consortia and Open-Source Approaches to Quantitative Drug Development Tools”. This was the first time in my short experience in this field that there has been a discussion on the concept of “sharing” in pharmacometrics. It was bold, new and exciting to see initiatives being taken in our community towards being more collaborative.

Continue reading